BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 6137429)

  • 1. Isolation and characterization of an embryonal carcinoma cell line lacking SSEA-1 antigen.
    Rosenstraus MJ
    Dev Biol; 1983 Oct; 99(2):318-23. PubMed ID: 6137429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variant embryonal carcinoma cells lacking SSEA-1 and Forsmann antigens remain developmentally pluripotent.
    Buckalew JJ; Sterman B; Rosenstraus M
    Dev Biol; 1985 Jan; 107(1):134-41. PubMed ID: 2856907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cultured stem-cells from human testicular teratomas: the nature of human embryonal carcinoma, and its comparison with two types of yolk-sac carcinoma.
    Pera MF; Blasco Lafita MJ; Mills J
    Int J Cancer; 1987 Sep; 40(3):334-43. PubMed ID: 2442105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation and characterization of peanut agglutinin-resistant embryonal carcinoma cell-surface variants.
    Rosenstraus MJ; Hannis M; Kupatt LJ
    J Cell Physiol; 1982 Aug; 112(2):162-70. PubMed ID: 6126483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishment of a pluripotent embryonal carcinoma cell line not expressing SSEA-1 and ECMA-7 phenotypes.
    Gregorová S; Loudová M; Dohnal K; Nosek J; Forejt J
    Cell Differ; 1984 Dec; 15(2-4):87-92. PubMed ID: 6152581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A pluripotent human stem-cell clone isolated from the TERA-2 teratocarcinoma line lacks antigens SSEA-3 and SSEA-4 in vitro, but expresses these antigens when grown as a xenograft tumor.
    Andrews PW; Damjanov I; Simon D; Dignazio M
    Differentiation; 1985; 29(2):127-35. PubMed ID: 2412924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Globo-series carbohydrate antigens are expressed in different forms on human and murine teratocarcinoma-derived cells.
    Krupnick JG; Damjanov I; Damjanov A; Zhu ZM; Fenderson BA
    Int J Cancer; 1994 Dec; 59(5):692-8. PubMed ID: 7960243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SSEA-1, a stage-specific embryonic antigen of the mouse, is carried by the glycoprotein-bound large carbohydrate in embryonal carcinoma cells.
    Ozawa M; Muramatsu T; Solter D
    Cell Differ; 1985 May; 16(3):169-73. PubMed ID: 2860973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Embryonal carcinoma cells differentiate into parietal endoderm via an intermediate stage corresponding to primitive endoderm.
    Damjanov I; Zhu ZM; Andrews PW; Fenderson BA
    In Vivo; 1994; 8(6):967-73. PubMed ID: 7772748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coordinate expression of X and Y haptens during murine embryogenesis.
    Fenderson BA; Holmes EH; Fukushi Y; Hakomori S
    Dev Biol; 1986 Mar; 114(1):12-21. PubMed ID: 2869992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-molecular-weight glycoproteins are the major carriers of the carbohydrate differentiation antigens I, i and SSEA-1 of mouse teratocarcinoma cells.
    Childs RA; Pennington J; Uemura K; Scudder P; Goodfellow PN; Evans MJ; Feizi T
    Biochem J; 1983 Dec; 215(3):491-503. PubMed ID: 6197967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamic heterogeneity: metastatic variants to liver are generated spontaneously in mouse embryonal carcinoma cells.
    Harris JF; Best MW
    Clin Exp Metastasis; 1988; 6(6):451-62. PubMed ID: 2900709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retinoic acid induces neuronal differentiation of a cloned human embryonal carcinoma cell line in vitro.
    Andrews PW
    Dev Biol; 1984 Jun; 103(2):285-93. PubMed ID: 6144603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complementation analyses of differentiation-defective embryonal carcinoma cells.
    McCue PA; Gubler ML; Maffei L; Sherman MI
    Dev Biol; 1984 Jun; 103(2):399-408. PubMed ID: 6144604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell-surface antigens of a clonal human embryonal carcinoma cell line: morphological and antigenic differentiation in culture.
    Andrews PW; Goodfellow PN; Shevinsky LH; Bronson DL; Knowles BB
    Int J Cancer; 1982 May; 29(5):523-31. PubMed ID: 7095898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell surface glycoproteins as markers in monitoring in vitro differentiation of embryonal carcinoma cells.
    Muramatsu T
    Cell Differ; 1984 Dec; 15(2-4):101-8. PubMed ID: 6152579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Murine embryonal carcinoma cell-surface sialyl LeX is present on a novel glycoprotein and on high-molecular-weight lactosaminoglycan.
    Rosenman SJ; Fenderson BA; Hakomori SI
    Exp Cell Res; 1989 Feb; 180(2):326-40. PubMed ID: 2464500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of SSEA-1 on human renal tumors.
    Liebert M; Jaffe R; Taylor RJ; Ballou BT; Solter D; Hakala TR
    Cancer; 1987 Apr; 59(8):1404-8. PubMed ID: 2880658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different patterns of glycolipid antigens are expressed following differentiation of TERA-2 human embryonal carcinoma cells induced by retinoic acid, hexamethylene bisacetamide (HMBA) or bromodeoxyuridine (BUdR).
    Andrews PW; Nudelman E; Hakomori S; Fenderson BA
    Differentiation; 1990 Apr; 43(2):131-8. PubMed ID: 2373286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An adhesion-defective variant of F9 embryonal carcinoma cells fails to differentiate into visceral endoderm.
    Grover A; Rosentraus MJ; Sterman B; Snook ME; Adamson ED
    Dev Biol; 1987 Mar; 120(1):1-11. PubMed ID: 2434373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.